Table 1.
Clinicopathological parameters | Total Cases (n) | IHC Staining of NCAPG | χ2 | P | |||
---|---|---|---|---|---|---|---|
Low expression | High expression | ||||||
Score 0 | Score 1–4 | Score 5–8 | Score 9–12 | ||||
Age(years) | |||||||
≤40 | 62 | 11 | 38 | 10 | 3 | 7.927 | 0.007* |
>40 | 78 | 5 | 39 | 18 | 16 | ||
Sex | |||||||
Male | 96 | 9 | 53 | 18 | 16 | 0.466 | 0.566 |
Female | 44 | 7 | 24 | 10 | 3 | ||
Histological grade (WHO) | |||||||
WHO 1 | 17 | 16 | 1 | 0 | 0 | 51.944 | <0.001* |
WHO 2 | 64 | 7 | 49 | 8 | 0 | ||
WHO 3 | 40 | 2 | 16 | 13 | 9 | ||
WHO 4 | 19 | 0 | 3 | 6 | 10 | ||
Recurrence | |||||||
With | 71 | 4 | 42 | 15 | 10 | 0.174 | 0.723 |
Without | 69 | 12 | 35 | 13 | 9 | ||
Ki-67 (IHC) | |||||||
<5% | 69 | 10 | 39 | 14 | 6 | 2.6 | 0.452 |
5%–10% | 44 | 4 | 27 | 8 | 5 | ||
10%–20% | 12 | 1 | 5 | 5 | 1 | ||
>20% | 15 | 1 | 8 | 3 | 3 | ||
GFAP (IHC) | |||||||
Low (+) | 66 | 8 | 38 | 11 | 9 | 0.822 | 0.663 |
Middle (++) | 65 | 6 | 36 | 18 | 5 | ||
High (+++) | 9 | 2 | 5 | 1 | 1 |
Significant P-values are shown in italics, *P < 0.05.